Literature DB >> 19911151

Theophylline-associated status epilepticus in an infant: pharmacokinetics and the risk of suppository use.

Zenichiro Kato1, Atsushi Yamagishi, Mitsuhiro Nakamura, Naomi Kondo.   

Abstract

BACKGROUND: Theophylline has been widely used to treat asthma, but recent studies have revealed that the possible risks for seizure may result in the revision of the therapeutic guidelines.
METHODS: An 8-month-old boy who had been treated with oral sustained-release theophylline and additional aminophylline suppository was hospitalized. A combination of diazepam, lidocaine and thiopental was required to stop his convulsion.
RESULTS: The pharmacokinetic study indicated that the usage of a sustained-release formula should not usually be over 15 mg/ml, but the additional use of an aminophylline suppository elevated the concentration to over 20 mg/ml and resulted in the severe adverse effects.
CONCLUSION: The parents of children and also physicians should be educated to ensure the proper use of the suppository formula.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19911151     DOI: 10.1007/s12519-009-0061-y

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  8 in total

1.  Intrinsic factors for unbound theophylline.

Authors:  Zenichiro Kato; Osamu Fukutomi; Naomi Kondo
Journal:  J Investig Allergol Clin Immunol       Date:  2002       Impact factor: 4.333

2.  Severe toxic effects from aminophylline and theophylline suppositories in children.

Authors:  A C NOLKE
Journal:  J Am Med Assoc       Date:  1956-06-23

3.  Theophylline and status epilepticus in children.

Authors:  D W Dunn; H U Parekh
Journal:  Neuropediatrics       Date:  1991-02       Impact factor: 1.947

4.  Developmental changes of unbound theophylline.

Authors:  Z Kato; O Fukutomi; N Kondo
Journal:  Ann Allergy Asthma Immunol       Date:  1998-06       Impact factor: 6.347

5.  Theophylline-associated status epilepticus resulting in quadriplegia.

Authors:  Z Kato; K Yasuda; N Shimozawa; N Kondo; T Horiuchi
Journal:  Ann Allergy Asthma Immunol       Date:  1997-03       Impact factor: 6.347

6.  The relationship between drug treatment and the clinical characteristics of febrile seizures.

Authors:  Wakako Haruyama; Tatsuo Fuchigami; Yukio Noguchi; Ayumi Endo; Koji Hashimoto; Yasuji Inamo; Yukihiko Fujita; Shigeru Takahashi; Hideo Mugishima
Journal:  World J Pediatr       Date:  2008-08       Impact factor: 2.764

7.  Prediction of steady-state serum theophylline concentration in children by first-order and zero-order absorption models.

Authors:  Z Kato; O Fukutomi; M Yamazaki; N Kondo; N Imaeda; T Orii
Journal:  Int J Clin Pharmacol Ther       Date:  1994-05       Impact factor: 1.366

8.  First-line therapy for theophylline-associated seizures.

Authors:  H Yoshikawa
Journal:  Acta Neurol Scand Suppl       Date:  2007
  8 in total
  1 in total

Review 1.  A call for action: Comparative effectiveness research in asthma.

Authors:  Jerry A Krishnan; Michael Schatz; Andrea J Apter
Journal:  J Allergy Clin Immunol       Date:  2010-09-19       Impact factor: 10.793

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.